Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Array Biopharma (ARRY)
Technical Analysis Report for USA stock ARRY Array Biopharma. Dated: 05 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma then click here. or read Experts views on Array Biopharma or Forecast & share price targets of Array Biopharma
Array Biopharma Opened at 8.18 and Closed at: 7.92, which is -3.54% of previous session's close. It moved within a range of 7.82 and 8.18
The session was a Bearish session with an average volume of 4633800, which is 38.02% of previous session's volumes.
Support for tomorrow is 7.69 and resistance for tomorrow is 8.05
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 7.77, 7.61 resistance for tomorrow's hourly charts is 8.13, 8.33
10 Day SMA for Array Biopharma (ARRY) is 7.55 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Array Biopharma (ARRY) is 7.76 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Array Biopharma (ARRY) is 8.37 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 8 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Array Biopharma is 7.06 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Array Biopharma is at 7.76 and 200 DMA is at 7.06, while 50 DMA and 100 DMA are at 8.37 and 8 respectively
Array Biopharma (ARRY) moving average of 20 SMA is at 7.76 and 20 EMA is at 7.79
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Fri Dec | 7.92 | 7.76 | 7.79 |
| 04 Thu Dec | 8.20 | 7.79 | 7.78 |
| 03 Wed Dec | 7.79 | 7.79 | 7.74 |
| 02 Tue Dec | 7.47 | 7.79 | 7.73 |
| 01 Mon Dec | 7.47 | 7.85 | 7.76 |
| 28 Fri Nov | 7.51 | 7.91 | 7.79 |
Array Biopharma (ARRY) moving average of 50 SMA is at 8.37 and 50 EMA is at 8.05
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Fri Dec | 7.92 | 8.37 | 8.05 |
| 04 Thu Dec | 8.20 | 8.37 | 8.06 |
| 03 Wed Dec | 7.79 | 8.37 | 8.05 |
| 02 Tue Dec | 7.47 | 8.36 | 8.06 |
| 01 Mon Dec | 7.47 | 8.38 | 8.08 |
| 28 Fri Nov | 7.51 | 8.39 | 8.1 |
Array Biopharma (ARRY) moving average of 100 SMA is at 8 and 100 EMA is at 7.88
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Fri Dec | 7.92 | 8 | 7.88 |
| 04 Thu Dec | 8.20 | 7.99 | 7.88 |
| 03 Wed Dec | 7.79 | 7.99 | 7.87 |
| 02 Tue Dec | 7.47 | 7.98 | 7.87 |
| 01 Mon Dec | 7.47 | 7.98 | 7.88 |
| 28 Fri Nov | 7.51 | 7.98 | 7.89 |
Array Biopharma (ARRY) moving average of 200 SMA is at 7.06 and 200 EMA is at 7.72
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Fri Dec | 7.92 | 7.06 | 7.72 |
| 04 Thu Dec | 8.20 | 7.05 | 7.72 |
| 03 Wed Dec | 7.79 | 7.04 | 7.72 |
| 02 Tue Dec | 7.47 | 7.04 | 7.72 |
| 01 Mon Dec | 7.47 | 7.03 | 7.72 |
| 28 Fri Nov | 7.51 | 7.03 | 7.72 |
Msa Safety has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Msa Safety, about 9.7% more returns!
Becton Dickinson has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Becton Dickinson, about 16.64% more returns!
Zymeworks Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Zymeworks Inc, about 69.73% more returns!
Tandem Diabetes has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Tandem Diabetes, about 36.22% more returns!
Replimune Group has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Replimune Group, about 34.95% more returns!
Array Biopharma has performed better than Pulmatrix Inc in short term. Holding Array Biopharma could be a better choice for now!
Nucana Plc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Nucana Plc, about 20.9% more returns!
Moleculin Biotech has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Moleculin Biotech, about 1385.13% more returns!
Microbot Medical has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Microbot Medical, about 23.76% more returns!
Lemaitre Vascular has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Lemaitre Vascular, about 4.94% more returns!
Integra Lifesciences has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Integra Lifesciences, about 17.55% more returns!
Healthcare Services has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Healthcare Services, about 16.97% more returns!
Establishment Labs has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Establishment Labs, about 16.4% more returns!
Dare Bioscience has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Dare Bioscience, about 4.85% more returns!
Corvus Pharmaceuticals has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Corvus Pharmaceuticals, about 23.5% more returns!
Array Biopharma has performed better than Biotelemetry Inc in short term. Holding Array Biopharma could be a better choice for now!
Aytu Bioscience has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Aytu Bioscience, about 16.94% more returns!
Assembly Biosciences has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Assembly Biosciences, about 19.79% more returns!
Agenus Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Agenus Inc, about 6.32% more returns!
Array Biopharma Technical analysis of indicators
Price action analysis of Array Biopharma (ARRY) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Array Biopharma in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Array Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.47 and Array Biopharma ARRY stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Array Biopharma ARRY stock. Volume based technical analysis of Array Biopharma ARRY stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ARRY Experts View which covers a lot of information including buying and selling signals
ARRY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Array Biopharma or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


